FDA Approves First Drug for Steroid-Refractory Acute Graft-Versus-Host Disease (GVHD)
In 2019 Incyte’s drug Jakafi (ruxolitinib) became the first medication FDA approved for the treatment of steroid-refractory acute GVHD in […]
Blog
Hot off the Press: FDA Approves New Treatment for Heart Failure with Reduced Ejection Fraction
Hot off the Press: FDA Approves New Treatment for Heart Failure with Reduced Ejection Fraction On May 5, 2020 after
Researchers provide new insights into hearing loss
Researchers provide new insights into hearing loss Between one-quarter and one-third of individuals older than 65 experience age related hearing
How the Elderly Can Manage the Mental Health Impacts of the COVID-19 Pandemic
Due to the strict precautions many geriatric adults are being recommended to take by the CDC, for many patients this